1 patent currently held
207 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4 more records may belong here and await a decision; they are not counted.
The next term ends in Jul 2027. from the record
Of the 207 now held by other companies, 201 name Merck Sharp and Dohme LLC as their current owner, and 6 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Jul 2027
Next term end
1
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Formerly held, still cited
Notable
Ends Jun 2027 · High confidence
Cited by 114 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
now held by Merck Sharp & Dohme LLC
Also notable
Ends Oct 2027 · High confidence
Cited by 68 later US patents, top 10% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
now held by Merck Sharp & Dohme LLC
Also notable
Ends Apr 2029 · High confidence
Cited by 61 later US patents, top 10% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer caps this term to an earlier patent's.
now held by Merck Sharp & Dohme Corp.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
- 15 terms have ended since Aug 22, 2026
- Nov 19 US 7,816,380 1-Hydroxycycloalkanecarboxamide Derivatives · term ended
- Nov 10 US 8,003,653 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease · term ended
- Oct 25 US 7,700,103 Optimized Expression of HPV 52 L1 in Yeast · term ended
- Oct 23 US 7,872,024 Benzothiophene Hydroxamic Acid Derivatives with Carbamate, Urea, Amide and Sulfonamide Substitutions · term ended
- Oct 23 US 7,772,238 Benzothiophene Hydroxamic Acid Derivatives · term ended
- Oct 21 US 8,865,707 Cholesteryl Ester Transfer Protein Inhibitors · lapsed on the fee record
- Oct 13 US 7,598,398 Acyl Indoles, Compositions Containing Such Compounds and Methods of Use · term ended
- Oct 10 US 7,829,597 Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease · term ended
- Sep 28 US 7,745,644 Antibiotic Compounds · term ended
- Sep 26 US 7,700,611 Synthesis and Crystalline Forms of NPY5 Antagonist · term ended
- Sep 23 US 8,843,356 Computer systems and methods for associating genes with traits using cross species data · lapsed on the fee record
- Aug 31 US 7,592,360 3-Fluoro-PIPERIDINES as NMDA/NR2B Antagonists · term ended
- Aug 30 US 7,659,264 CGRP Receptor Antagonists · term ended
- Aug 28 US 8,026,260 Histone Deacetylase Inhibitors with Aryl-Pyrazolyl-Motifs · term ended
- Aug 28 US 7,834,034 Benzothiophene Derivatives · term ended
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 1 of 1
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,134,038 | Oligomerisation of Olefinic Compounds in the Presence of an Oligomerisation Catalyst, and a Catalyst Activator Including a Halogenated Organic Group In force · High confidence | In force | High confidence |
Also on record, not counted in the 1: 207 patents in force now held by others · 704 patents ended · 514 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 patents carry no fee events. That is a gap in the record, not evidence of lapse, so status falls back to the computed term
22 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed